Status:
public
Videos: (
0
) Documents: (
0
) Comments: (
0
)
Group description
Percutaneous Hepatic Perfusion (PHP) is a regionalized, minimally-invasive approach to cancer treatment currently undergoing Phase II and Phase III clinical testing. PHP treats a variety of hepatic tumors by isolating the liver and exposing the organ to high-dose chemotherapy.
Group Videos
No videos have been added jet. You may join this group and add yours now.
Group Documents
No documents have been added jet. You may join this group and add yours now.
News
- Vessix Vascular to Present V2 Renal Denervation Systemâ„¢ for Hypertension at TRenD Workshop 2012
LAGUNA HILLS, Calif., Feb. 13, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that it will make its first ... - Boston Scientific Announces CE Mark Approval and Euro.
Boston Scientific Corporation announces CE Mark approval of the Infinion(TM) 16 Percutaneous Lead for its Precision Plus(TM) Spinal Cord Stimulator (SCS) System, the first rechargeable SCS device for chronic pain management. - CardioKinetix Receives Expanded CE Mark Approval for World's First Percutaneous Left Ventricular Partitioning Device ...
MENLO PARK, CA-- - CardioKinetix Inc., a medical device company that has developed a novel transcatheter implant called the Parachuteâ„¢ Ventricular Partitioning Device , announced today that it has received ... - Endologix Completes Enrollment in PEVAR Randomized Trial
IRVINE, Calif. -- Endologix, Inc. , developer and marketer of innovative treatments for aortic disorders, announced today the completion of patient enrollment in the Company's prospective, multicenter, ... - Boston Scientific Announces CE Mark Approval and European Launch for New Infinionâ„¢ 16 Percutaneous Lead for ...
PARIS and MIAMI BEACH, Florida, February 3, 2012 /PRNewswire/ Boston Scientific Corporation announces CE Mark approval of the Infinion(TM) 16 Percutaneous Lead for its Precision Plus(TM) Spinal Cord Stimulator (SCS) System, the first … - Boston Scientific Announces CE Mark Approval and European Launch for New Infinion? 16 Percutaneous Lead for Precision ...
Boston Scientific Corporation: Paris and Miami Beach, Florida (ots/PRNewswire) - Boston Scientific Corporation announces CE Mark approval of the Infinion(TM) 16 Percutaneous Lead for its Precision Plus(TM) Spinal Cord Stimulator (SCS) System, the first rechargeable SCS device ... - VasoStitch Completes Successful In Vivo Study of Its Breakthrough Access-and-Closure System for Nonsurgical Deployment ...
VasoStitch, a start-up medical technology company, announced today that it has successfully completed its first in vivo study of its percutaneous access-and-closure system for the nonsurgical deployment of large-diameter transcatheter therapeutic devices, such as Transcatheter Aortic Valve Implants and Endovascular Aneurysm Repair devices. - Vessix to Present V2 Renal Denervation Systemâ„¢ for Hypertension at LINC 2012
LAGUNA HILLS, Calif. , Jan. 18, 2012 /PRNewswire/ -- Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology, announced today that the first public presentation ... - Research and Markets: Innovations in Transcatheter Stents and Transcatheter Aortic Valves: examining devices ...
Research and Markets has announced the addition of the "Innovations in Transcatheter Stents and Transcatheter - Interventional Spine, Inc. Announces FDA Clearance of its Opticageâ„¢ Expandable Interbody for Treatment of Degenerative ...
IRVINE, Calif., Jan. 26, 2012 /PRNewswire/ -- Interventional Spine, Inc. today announced the FDA clearance of its Opticageâ„¢ Expandable Intervertebral Body Fusion Device.(Logo: http://photos.prnewswire.com/prnh/20100419/LA88318LOGO ...